These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
211 related items for PubMed ID: 6229254
1. Effect of docosahexaenoic acid (DHA) on arachidonic acid metabolism and platelet function. Rao GH, Radha E, White JG. Biochem Biophys Res Commun; 1983 Dec 16; 117(2):549-55. PubMed ID: 6229254 [Abstract] [Full Text] [Related]
2. Comparative pharmacology of cyclooxygenase inhibitors on platelet function. Rao GH, White JG. Prostaglandins Leukot Med; 1985 Apr 16; 18(1):119-31. PubMed ID: 3159025 [Abstract] [Full Text] [Related]
3. Docosahexaenoic acid (C22:6 omega 3) and linoleic acid are anti-aggregatory, and alter arachidonic acid metabolism in human platelets. Srivastava KC. Prostaglandins Leukot Med; 1985 Mar 16; 17(3):319-27. PubMed ID: 3158002 [Abstract] [Full Text] [Related]
4. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid. Brammer JP, Maguire MH. Br J Pharmacol; 1984 May 16; 82(1):61-72. PubMed ID: 6428500 [Abstract] [Full Text] [Related]
5. Inhibitors of Na+/H+ exchange block stimulus-provoked arachidonic acid release in human platelets. Selective effects on platelet activation by epinephrine, ADP, and lower concentrations of thrombin. Sweatt JD, Johnson SL, Cragoe EJ, Limbird LE. J Biol Chem; 1985 Oct 25; 260(24):12910-9. PubMed ID: 2997148 [Abstract] [Full Text] [Related]
6. Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions. Minkes M, Stanford N, Chi MM, Roth GJ, Raz A, Needleman P, Majerus PW. J Clin Invest; 1977 Mar 25; 59(3):449-54. PubMed ID: 190267 [Abstract] [Full Text] [Related]
7. Benzodiazepines inhibit human platelet activation: comparison of the mechanism of antiplatelet actions of flurazepam and diazepam. Romstedt K, Huzoor-Akbar. Thromb Res; 1985 May 15; 38(4):361-74. PubMed ID: 2990062 [Abstract] [Full Text] [Related]
8. Iron chelators inhibit human platelet aggregation, thromboxane A2 synthesis and lipoxygenase activity. Barradas MA, Jeremy JY, Kontoghiorghes GJ, Mikhailidis DP, Hoffbrand AV, Dandona P. FEBS Lett; 1989 Mar 13; 245(1-2):105-9. PubMed ID: 2494068 [Abstract] [Full Text] [Related]
13. Platelet desensitization by arachidonic acid is associated with the suppression of endoperoxide/thromboxane A2 binding to the membrane receptor. Sato T, Hashizume T, Nakao K, Akiba S, Fujii T. Biochim Biophys Acta; 1989 Aug 18; 992(2):168-73. PubMed ID: 2503041 [Abstract] [Full Text] [Related]
14. Thrombin pretreatment of human platelets impairs thromboxane A2 synthesis from endogenous precursors in the presence of normal cyclooxygenase activity. Reimers HJ, Scharf RE, Baker RK. Blood; 1984 Apr 18; 63(4):858-65. PubMed ID: 6231068 [Abstract] [Full Text] [Related]
15. Irreversible platelet aggregation does not depend on lipoxygenase metabolites. Rao GH, Radha E, White JG. Biochem Biophys Res Commun; 1985 Aug 30; 131(1):50-7. PubMed ID: 3929780 [Abstract] [Full Text] [Related]
16. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA. Krishnamurthi S, Joseph S, Kakkar VV. Biochim Biophys Acta; 1987 Mar 11; 927(3):429-36. PubMed ID: 3101746 [Abstract] [Full Text] [Related]
19. Arachidonic acid metabolism in the neonatal platelet. Stuart MJ, Allen JB. Pediatrics; 1982 Jun 11; 69(6):714-8. PubMed ID: 6804924 [Abstract] [Full Text] [Related]